Research Lung Cancer Medical Oncology
Combining targeted therapies known as tyrosine kinase inhibitors (TKIs) can be an effective way to treat a mutation-driven form of lung cancer in cases where tumors develop resistance to treatment and where cancer has spread to other parts of the body, a University of Colorado Cancer Center member reports.
Research Breast Cancer Drug Development Medical Oncology
Research led by University of Colorado Cancer Center members points to a combination of drugs as a potential treatment option for a type of aggressive breast cancer.
Research Head and Neck Cancer Medical Oncology
After eight years of work by a pair of University of Colorado Cancer Center leaders on a new way to attack various cancers, the next stage in their quest to bring their therapy to patients is one of nine research endeavors receiving funding from the Anschutz Acceleration Initiative (AAI).
Cancer Multidisciplinary Clinic Medical Oncology
A cancer diagnosis is a serious matter – which is why a patient who gets one should seriously consider getting a second opinion.
Research Breast Cancer Medical Oncology
The focus of a University of Colorado Cancer Center member’s research career has been a quest for new, better therapies for patients with breast cancer. That quest by Elena Shagisultanova, MD, PhD, has resulted in a clinical trial pointing the way to an oral treatment that’s more tolerable than intensive chemotherapy for patients with a type of metastatic breast cancer that accounts for about 20% of cases among women under age 45.
Gripped
March 27, 2024
Just 18 months after his leukemia diagnosis and on the brink of a bone marrow transplant, Chen defied the odds with an inspiring ascent. Reflecting on his journey, Chen's resilience shines through as he remains optimistic and determined for the future.
EurekAlert
March 06, 2024
Researchers at the University of Colorado Anschutz Medical Campus found that drugs like botox may slow head and neck cancer progression by targeting nerve interactions in tumor environments, impacting immune responses. This study could lead to new treatments for patients intolerant to traditional therapies.
Mile High Magazine
February 25, 2024
Christopher Lieu, MD speaks on March being Colorectal Cancer Awareness Month and the importance of screening.
National Institutes of Health (NIH)
February 21, 2024
In 2024, the network will launch a pilot study, known as the Vanguard Study on Multi-Cancer Detection, to address the feasibility of using multi-cancer detection (MCD) tests in future randomized controlled trials.
Mark Harden
